What is Grand Pharmaceutical Group Operating Cash Flow per Share?
Grand Pharmaceutical Group's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$0.48.
Grand Pharmaceutical Group's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.69.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Grand Pharmaceutical Group was 32.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Grand Pharmaceutical Group's Operating Cash Flow per Share or its related term are showing as below:
HKSE:00512'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -35.2 Med: 14.05 Max: 240.1
Current: 17.8
During the past 13 years, Grand Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 240.10% per year. The lowest was -35.20% per year. And the median was 14.05% per year.
HKSE:00512's 3-Year OCF Growth Rate is ranked better than 64.44% of 807
companies
in the Drug Manufacturers industry
Industry Median: 7.4
vs HKSE:00512: 17.80
Grand Pharmaceutical Group Operating Cash Flow per Share Historical Data
The historical data trend for Grand Pharmaceutical Group's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Grand Pharmaceutical Group Operating Cash Flow per Share Chart
Competitive Comparison of Grand Pharmaceutical Group's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.
Grand Pharmaceutical Group Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Grand Pharmaceutical Group's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Pharmaceutical Group Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Grand Pharmaceutical Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Grand Pharmaceutical Group (HKSE:00512) Business Description
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00512 has been successfully added to your 